Vietnam National Cancer Institute, Hanoi Oncology Hospital
Hanoi, 134000, Vietnam
NCT Number: NCT05262621
Study design A 2-arm, assessor-blinded randomised controlled trial will be conducted. The design will follow the Standard Protocol Items Recommendations for Interventional Trials (SPIRIT)
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Hanoi, 134000, Vietnam
Aim: To assess the effect of MCP on anxiety, depression and QoL of BGC patients receiving chemotherapy.
Objectives
Hypothesis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Practice muscle relaxation for 20 minutes once/a day
Right after practising progressive muscle relaxation, the participants will listen to relaxing music for 20 minutes
Time frame: ebaseline, T1 after 3 weeks, T2 after 6 weeks
it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for anxiety (DASS21-A). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the anxiety score can range from 0 to 42. The higher the score is the more severe anxiety. The score of 0-7 is normal, 8-9 mild, 10-14 moderate, 15-19 severe, +20 extremely severe.
Time frame: baseline, T1 after 3 weeks, T2 after 6 weeks
it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for depression (DASS21-D). A 4-point Likert-type scale ranging from 0 to 3 was designed on each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the depression score can range from 0 to 42. The higher the score is the more severe depression. The score of 0-9 is normal, 10-13 mild, 14-20 moderate, 21-27 severe, +28 extremely severe.
Time frame: baseline, T1 after 3 weeks, T2 after 6 weeks
it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for stress (DASS21-S). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the stress score can range from 0 to 42. The higher the score is the more severe stress. The score of 0-14 is normal, 15-18 mild, 19-25 moderate, 26-33 severe, +34 extremely severe.
Time frame: baseline, T1 after 3 weeks, T2 after 6 weeks
Coping will be measured using Brief COPE. The Brief-COPE is a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event.The scale can determine someone's primary coping styles with scores on the following three subscale:
Problem-Focussed Coping, Emotion-Focussed Coping, Avoidant Coping.A 4-point Likert-type scale ranging from 1 to 4 was designed on each item.
Time frame: baseline, T1 after 3 weeks, T2 after 6 weeks
coping will be measured using FACT-G.It evaluates in functional scales on Social/family well-being (SWB); Emotional well-being (EWB) and Functional well-being (FWB). Each item is scored in one of five categories of 0-4, with 'Not at all', 'A little bit', 'some what', 'Quite a bit' 'Very much'. The higher the score is the better quality of life." The possible range of scores is from 0 to 112.
Time frame: baseline, T1 after 3 weeks,
satisfaction of nursing care will be measured using numerical rating scale.(0-10) from 0 = completely dissatisfied with the care to 10 = completely satisfied with the care.
The Nethersole School of Nursing
Other
Effects of Music Intervention Combined With Progressive Muscle Relaxation on Anxiety, Depression and Quality of Life in Breast and Gynaecological Cancer Patients Receiving Chemotherapy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07598851
Anxiety Disorders, Behavior
Taichung, Taiwan
View Trial DetailsNCT05786482
Anxiety Disorders, Behavior
Edmonton, Alberta, Canada
View Trial DetailsNCT04867122
Anxiety Disorders, Behavior
Columbia, Missouri, United States
View Trial DetailsNCT03060096
Anxiety, Anxiety Disorders
Fort Smith, Arkansas, United States
View Trial Details